Fidler S - Search Results

1

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.

Ogbe A, Pace M, Bittaye M, Tipoe T, Adele S, Alagaratnam J, Aley PK, Ansari MA, Bara A, Broadhead S, Brown A, Brown H, Cappuccini F, Cinardo P, Dejnirattisai W, Ewer KJ, Fok H, Folegatti PM, Fowler J, Godfrey L, Goodman AL, Jackson B, Jenkin D, Jones M, Longet S, Makinson RA, Marchevsky NG, Mathew M, Mazzella A, Mujadidi YF, Parolini L, Petersen C, Plested E, Pollock KM, Rajeswaran T, Ramasamy MN, Rhead S, Robinson H, Robinson N, Sanders H, Serrano S, Tipton T, Waters A, Zacharopoulou P, Barnes E, Dunachie S, Goulder P, Klenerman P, Screaton GR, Winston A, Hill AV, Gilbert SC, Carroll M, Pollard AJ, Fidler S, Fox J, Lambe T, Frater J. Ogbe A, et al. Among authors: fidler s. JCI Insight. 2022 Apr 8;7(7):e157031. doi: 10.1172/jci.insight.157031. JCI Insight. 2022. PMID: 35192543 Free PMC article. Clinical Trial.

2

HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.

Scriba TJ, Zhang HT, Brown HL, Oxenius A, Tamm N, Fidler S, Fox J, Weber JN, Klenerman P, Day CL, Lucas M, Phillips RE. Scriba TJ, et al. Among authors: fidler s. J Clin Invest. 2005 Feb;115(2):443-50. doi: 10.1172/JCI23084. J Clin Invest. 2005. PMID: 15668739 Free PMC article.

3

Ultrasensitive detection and phenotyping of CD4+ T cells with optimized HLA class II tetramer staining.

Scriba TJ, Purbhoo M, Day CL, Robinson N, Fidler S, Fox J, Weber JN, Klenerman P, Sewell AK, Phillips RE. Scriba TJ, et al. Among authors: fidler s. J Immunol. 2005 Nov 15;175(10):6334-43. doi: 10.4049/jimmunol.175.10.6334. J Immunol. 2005. PMID: 16272285

4

Resistance to HIV drugs in UK may be lower in some areas.

Fox JM, Fidler S, Weber J. Fox JM, et al. Among authors: fidler s. BMJ. 2006 Jan 21;332(7534):179-80. doi: 10.1136/bmj.332.7534.179-c. BMJ. 2006. PMID: 16424507 Free PMC article. No abstract available.

5

Comparative potency of three antiretroviral therapy regimes in primary HIV infection.

Fidler S, Fraser C, Fox J, Tamm N, Griffin JT, Weber J. Fidler S, et al. AIDS. 2006 Jan 9;20(2):247-52. doi: 10.1097/01.aids.0000200530.71737.75. AIDS. 2006. PMID: 16511418 Clinical Trial.

6

Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART.

Sutherland R, Yang H, Scriba TJ, Ondondo B, Robinson N, Conlon C, Suttill A, McShane H, Fidler S, McMichael A, Dorrell L. Sutherland R, et al. Among authors: fidler s. AIDS. 2006 Apr 4;20(6):821-9. doi: 10.1097/01.aids.0000218545.31716.a4. AIDS. 2006. PMID: 16549965

7

Prevalence of primary genotypic resistance in a UK centre: Comparison of primary HIV-1 and newly diagnosed treatment-naive individuals.

Fox J, Hill S, Kaye S, Dustan S, McClure M, Fidler S, Mackie NE. Fox J, et al. Among authors: fidler s. AIDS. 2007 Jan 11;21(2):237-9. doi: 10.1097/01.aids.0000247577.26375.ef. AIDS. 2007. PMID: 17197816

8

Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort.

Fidler S, Fox J, Touloumi G, Pantazis N, Porter K, Babiker A, Weber J. Fidler S, et al. AIDS. 2007 Jun 19;21(10):1283-91. doi: 10.1097/QAD.0b013e3280b07b5b. AIDS. 2007. PMID: 17545704

9

Risk of HIV transmission in discordant partners.

Fox J, Fidler S. Fox J, et al. Among authors: fidler s. J HIV Ther. 2007 Jun;12(2):48-53. J HIV Ther. 2007. PMID: 17641573 Review. No abstract available.

10

Primary HIV infection: to treat or not to treat?

Fidler S, Fox J, Porter K, Weber J. Fidler S, et al. Curr Opin Infect Dis. 2008 Feb;21(1):4-10. doi: 10.1097/QCO.0b013e3282f428bf. Curr Opin Infect Dis. 2008. PMID: 18192779 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

373 results

Search Page